By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Pharmion Corporation 

2525 28th Street, Suite 200

Boulder  Colorado  80301  U.S.A.
Phone: 720-564-9100 Fax: 720-564-9191


SEARCH JOBS


Industry
Pharmaceutical






Company News
FDA Requests Label Change for Pharmion Corporation (PHRM)'s Tinzaparin 12/3/2008 7:35:27 AM
Celgene (CELG) Subsidiary Pharmion Corporation (PHRM) Withdraws European Marketing Application for Orplatna 8/14/2008 6:37:08 AM
Celgene Corporation (CELG) Completes $2.9 Billion Acquisition of Pharmion Corporation (PHRM) 3/10/2008 9:08:32 AM
Celgene Corporation (CELG) and Pharmion Corporation (PHRM) Announce Shareholder Vote in Favor of Acquisition of Pharmion Corporation (PHRM) 3/6/2008 9:13:53 AM
ISS Recommends Pharmion Corporation (PHRM) Shareholders Vote for Merger With Celgene (CELG) 2/27/2008 8:36:20 AM
Pharmion Corporation (PHRM) Announces 2007 Operating Results 2/19/2008 10:35:09 AM
Pharmion Corporation (PHRM) and MethylGene Announce U.S. Orphan Drug Designation Granted for MGCD0103 for the Treatment of Acute Myelogenous Leukemia 2/14/2008 8:01:55 AM
MethylGene and Pharmion Corporation (PHRM) Announce Orphan Drug Designation Granted by the European Medicines Evaluation Agency for MGCD0103 for the Treatment of Acute Myelogenous Leukemia 2/11/2008 10:00:41 AM
Pharmion Corporation (PHRM) and MethylGene Announce Orphan Drug Designation Granted by the European Medicines Agency (EMEA) for MGCD0103 for the Treatment of Acute Myelogenous Leukemia 2/11/2008 8:18:10 AM
Pharmion Corporation (PHRM) Release: EMEA Accepts for Review Vidaza(R) Marketing Authorization Application for Higher-Risk Myelodysplastic Syndromes 2/7/2008 8:27:35 AM
12345678910...
//-->